Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 923093 STAMFORD, CT

Position in XENE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,919,559
+$4,100,943 QoQ
Shares Held
545,387
+10.0% QoQ
Ownership
0.563%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#41
of 313 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Mar 31, 2026
CallValue
$2,756,310
CallShares
47,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. XENE ranks #3 (8.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 XENE
Xenon Pharmaceuticals Inc.
This page
545,387 $32,919,559

All Filings in XENE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,919,559 545,387
2026-03-31 $28,818,616 495,591
2026-03-31 $2,756,310 47,400
2025-12-31 $11,384,369 254,002
2025-12-31 $313,740 7,000
2025-09-30 $3,084,483 76,824
2025-09-30 $1,236,620 30,800
2024-12-31 $339,903 8,671
2024-09-30 $1,444,367 36,687
2024-06-30 $983,795 25,232
2024-03-31 $1,083,008 25,157
2023-12-31 $1,990,759 43,221
2023-03-31 $1,070,407 29,908
2022-06-30 $618,621 20,336